Lupin launches Molnulup for the treatment of COVID-19 in adults in India Clinical data suggests that it is effective on patients with co-morbidities
TB Alliance partners with Lupin for new therapy for highly drug-resistant TB Lupin intends to commercialise the anti-tuberculosis (TB) medicine in approximately 140 countries and territories, including many…
Lupin launches Digital Asthma Educator platform The platform is the latest initiative under Lupin’s long-running umbrella programme, Joint Airways Initiative (JAI), for patients…
Drug firms in India recall products from US While Lupin and Marksans Pharma are recalling diabetes drug, Aurobindo and Alembic are recalling psychiatric medication in the US…
Omron Healthcare partners with Lupin To strengthen respiratory disease management facilities Medical device maker Omron Healthcare India has joined hands…